HIF1A and cancer: Malignant tumor cells avoid recognition and destruction by both the innate and adaptive immune systems via the HIF-1, which is also associated with tumor cell immunotherapy resistance, radiotherapy resistance, and chemoresistance, enhancing cancer cells to proliferate and metastasize [60,61].